What Olfactive Biosolutions does

Olfactive Biosolutions is a privately-held food-molecule biotechnology company headquartered in San Carlos, California, founded in 2023. It operates the TruePath Receptor Platform, an end-to-end discovery system that uses proprietary cell lines, cloned human olfactory receptors, cellular assays, automation, and AI-driven docking (Boltz for structure prediction combined with smina/gnina/Autodock Vina scoring) to identify GRAS food-derived ligands that activate ectopic chemosensory receptors expressed outside the nose and tongue, primarily in the gut, to elicit drug-like physiological responses.

The company's commercial expression of this science is the Pivit line of precision-therapeutic consumer supplements. Pivit Weight Loss, a 120-capsule GRAS-ingredient formulation that activates gut ectopic receptors to stimulate endogenous GLP-1, GIP, and PYY secretion, launched via DTC e-commerce at $169 one-time / $149 monthly subscription on getpivit.com, with shipments excluded to Washington and Nevada. Pivit Blood Pressure represents a pipeline extension into cardiovascular indications. The company reports clinical-style evidence including ~12 lbs average weight loss over 12 weeks in a third-party medically supervised continuous glucose monitoring study with demonstrated dose-response causality, plus self-reported outcomes from 80 participants. Five granted US patents (weight loss and blood sugar Oct–Dec 2024, multiple hormone activation May 2025, blood pressure Oct 2024 and Jan 2025) protect method and composition.

Revenue mechanics run on three streams: DTC subscription/one-time supplement sales through own storefront, royalties-style licensing of Pivit formulations to food & beverage, CPG, supplements, and ingredients companies under sponsored JDA, field-of-use, or option-to-license structures, and patent/technology licensing to compounding pharmacies and life science collaborators. Customer segments are direct health consumers seeking non-prescription GLP-1-aligned alternatives to Ozempic-class drugs priced at $1,200/month, plus B2B F&B and supplement manufacturers seeking mechanism-led differentiation. No institutional funding rounds, ARR, or named B2B customers are disclosed; the company maintains an investor relations inbox and references openness to seed/Series A conversations, implying a pre-institutional capital posture. The company is led by ex-Del Monte Foods CEO Nils Lommerin, with Patagonia Provisions founder Birgit Cameron as CCO and CMO Dr. Christopher Maclay, supported by a scientific bench drawn from Osmo, Firmenich/Senomyx, and Aromyx.

Name

Olfactive Biosolutions

Legal name

Olfactive Biosolutions, Inc.

Website

https://olfactive.bio

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Olfactive Biosolutions is a San Carlos-based food-molecule biotechnology company that uses its TruePath Receptor Platform to identify GRAS food-derived ligands activating ectopic gut receptors, commercializing the Pivit line of precision supplements (weight loss, blood pressure) via DTC e-commerce and B2B licensing to food, beverage, CPG, and supplement partners.

Ownership category

akta.pro rank

Product category

Metabolic Health Supplements

NAICS

Food (Health) Supplement Retailers (456191)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends) (CRADAOAO)

akta.pro secondary industry

Weight Management & Metabolic Supplements (CRADAGAG)

Keywords

• Metabolic health supplements
• Food molecule biotechnology
• Ectopic receptor therapeutics
• GLP-1 activator supplements
• Ingredient licensing platform

Headquarters

HQ city

San Carlos

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Direct-to-Consumer Supplement Sales: Sells Pivit® line of precision-therapeutic products directly to consumers as supplements through e-commerce at getpivit.com. Offers both one-time purchases and monthly subscription plans.
2. Ingredient Licensing: Licenses Pivit formulations to food & beverage and consumer packaged goods companies for inclusion in their products such as snacks, bars, coffee and other products. Royalties-based model.
3. Technology and Patent Licensing: Licenses patents and technology to supplements companies and compounding pharmacies. Flexible deal structures include sponsored JDA, field-of-use licensing, option-to-license structures.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Olfactive Biosolutions discovers and formulates food-derived ligands (GRAS molecules such as cinnamaldehyde, lauric acid, benzyl acetate, eugenol, butyl butyryl lactate, and spearmint oil) that modulate ectopic chemosensory receptors throughout the body to produce drug-like physiological effects. The company commercializes this science through the Pivit line of precision-therapeutic supplements (starting with Pivit Weight Loss, an oral GLP-1/GIP/PYY activator) sold direct-to-consumer, while licensing its TruePath platform and formulations to food & beverage, CPG, supplements, and compounding pharmacy partners.

Product overview

Olfactive Biosolutions operates a platform-plus-products model anchored by the TruePath Receptor Platform—a discovery engine that identifies food-derived molecules capable of activating ectopic chemosensory receptors throughout the body. The company commercializes its science through the Pivit line of precision-therapeutic supplements, starting with Pivit Weight Loss (GLP-1 activator for metabolic health and satiety) and Pivit Blood Pressure (cardiovascular health). Pivit formulations are available direct-to-consumer as supplements and are also licensed as functional food ingredients to food & beverage, CPG, and supplement partners. The platform is designed to generate a pipeline of receptor-validated formulations across multiple chronic health categories.

Differentiator

Problem solved

Functional benefit

Brands

• Pivit: Line of precision-therapeutic products comprising proprietary formulations of food, beverage or fragrance molecules designed to activate ectopic receptors in the gut for beneficial physiological effects such as GLP-1 and GIP secretion for weight loss and blood sugar reduction. Also includes formulations for blood pressure management.

Products and services

• Pivit Weight Loss An oral GLP-1 activator supplement made with GRAS food-derived molecules (cinnamaldehyde, lauric acid, benzyl acetate, eugenol, butyl butyryl lactate, spearmint oil) that stimulates the body's own incretin response by activating ectopic chemosensory receptors in the gut, prompting natural secretion of GLP-1, GIP, and PYY hormones. Available in 120-capsule bottles for direct-to-consumer purchase and as a licensable formulation for F&B and CPG partners.
• Pivit Blood Pressure A formulation under the Pivit line designed to reduce blood pressure through the same receptor platform approach as Pivit Weight Loss, using patented food-derived molecules that activate ectopic receptors for cardiovascular health. Covered by two granted US patents.
• TruePath Receptor Platform An end-to-end discovery system for ligand interactions with chemosensory GPCRs, including olfactory receptors (ORs) and taste receptors (TRs) throughout the body as ectopic receptors. Combines proprietary cell lines, DNA sequences, plasmids, protein expression techniques, cellular assays, liquid handling robots, and AI-powered analysis software to identify food-based ligands that modulate ectopic receptors. Licensed to B2B partners for co-development of functional ingredients.

Quantifiable outcome

• ~12 lbs average weight loss over 12 weeks in third-party medically supervised study
• +4 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Food & Beverage CompaniescoreOEM/ Whitelabel/ Licensing PartnerLicenses Pivit formulations for incorporation into food and beverage products such as snacks, bars, coffee and other functional products. Target partner companies with distribution power seeking mechanism-led differentiation. Deal structures include sponsored JDA, field-of-use licensing, option-to-license, and multi-functional food and beverage co-development.
• Consumer Packaged Goods CompaniescoreOEM/ Whitelabel/ Licensing PartnerPartners with CPG companies to integrate Pivit formulations into everyday consumer products. Flexible deal structures available including ingredients licensing, co-dev, exclusivity, and more. Target companies with distribution power that value mechanism-led differentiation over commodity ingredients.
• Supplements CompaniescoreOEM/ Whitelabel/ Licensing PartnerLicenses Pivit formulations to supplements companies looking to incorporate receptor-validated natural ingredients. Provides mechanism-backed formulations with documented outcomes for differentiation in crowded supplements market.
• Compounding PharmaciesminorOEM/ Whitelabel/ Licensing PartnerLicenses patents and technology to compounding pharmacies for customized natural formulations. Extends reach of natural metabolic actives beyond standard consumer products.
• Ingredients CompaniescoreOEM/ Whitelabel/ Licensing PartnerProvides B2B ingredients for brand partners seeking novel receptor-targeted functional ingredients. Targets companies looking for repeatable innovation rather than just single SKU products.
• Life Science CompaniesminorStrategic or Co-development PartnerCollaborates with life science companies on research partnerships that combine platform data and biological insight. Explores novel receptor targets and ligand classes and synergies.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Thorne:
• Firmenich (now part of dsm-firmenich): Global flavor and fragrance house (and acquirer of Senomyx) that built a receptor-based ingredient discovery platform for novel tastants and flavor molecules. Highly comparable on the receptor-ligand ingredient discovery model and is the prior employer of Olfactive's Chief Scientist.
• Ginkgo Bioworks: Cell programming and bioengineering platform that develops and licenses novel organisms and ingredients across food, nutrition, and industrial customers. Comparable as a platform-plus-ingredients business model, though at significantly larger scale and broader scope.
• Nestlé Health Science: Global nutrition and consumer health subsidiary of Nestlé with a strong position in metabolic health, GLP-1 companion products, and medical nutrition. Comparable as both a potential B2B licensing partner and a formidable competitor in the natural/metabolic health category Pivit is targeting.

Direct peers

• Pendulum: Microbiome-based metabolic health supplement company (notably Pendulum Glucose Control) that markets mechanism-backed, clinically studied natural ingredients for blood sugar and weight management. Highly comparable on the science-led, DTC, natural-metabolic-active positioning.
• Osmo: AI-driven olfactory science company mapping how molecules smell and taste. Closest comparable on the receptor-discovery technology layer, and Olfactive's Chief Scientist Dr. Andrew Patron joined from Osmo, bringing its discovery playbook into Olfactive's food-ligand work.
• Supergut: DTC supplement brand selling prebiotic fiber blends explicitly positioned to boost natural GLP-1 and support metabolic health. Directly competes with Pivit Weight Loss for the same GLP-1-alternative consumer and overlaps in ingredients, format (powders/capsules), and positioning.

Emerging players

• Conagen: Biology-based ingredient discovery company using fermentation and synthetic biology to produce novel functional ingredients for food, beverage, supplement, and pharma customers. Comparable on the platform-driven B2B ingredient licensing model, though focused on engineered molecules rather than food-derived ones.
• Ritual: DTC, science-forward supplement brand with transparent ingredient sourcing and a subscription model. Comparable on the modern DTC supplement playbook, subscription pricing architecture, and brand-led positioning around clinically supported ingredients.
• Codexis: Protein engineering company that develops novel enzymes and biotherapeutics, including for food and nutrition applications. Comparable as a science-driven ingredient/biocatalyst platform that licenses or sells novel molecules into CPG and pharma supply chains.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/olfactiveai

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Olfactive Biosolutions